Ibrahim, A. S., Spellberg, B. J., Avanesian, V., Fu, Y., & Edwards, J. E. (2006). The Anti-Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis. American Society for Microbiology.

Ibrahim, Ashraf S., Brad J. Spellberg, Valentina Avanesian, Yue Fu, and John E. Edwards. The Anti-Candida Vaccine Based On the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis. American Society for Microbiology, 2006.

Ibrahim, Ashraf S., et al. The Anti-Candida Vaccine Based On the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis. American Society for Microbiology, 2006.